Table 4.
Performance in rule-in using biomarkers and ECG.
| Rule-In Observations: | |||
|---|---|---|---|
| All (n = 1220) |
Non-AMI (n = 975) |
AMI (n = 245) |
|
| hs-TnI 1 h > 6 ng/L AND hs-TnI increase ≥ 12 ng/L compared to hs-TnI 0 h | 177 (15.3%) |
27 (2.9%) |
150 (65.5%) |
| hs-TnI 1 h > 6 ng/L AND hs-TnI increase ≥ 12 ng/L compared to hs-TnI 0 h AND suPAR 0 h ≥ 3.7 ng/mL | 93 (8.1%) |
17 (1.8%) |
76 (33.2%) |
| suPAR 0 h ≥ 3.7 ng/mL | 533 (43.7%) |
404 (41.4%) |
129 (52.7%) |
AMI = acute myocardial infarction, hs-TnI = high-sensitivity troponin I, suPAR = soluble urokinase-type plasminogen activator receptor.